vs
Side-by-side financial comparison of APTARGROUP, INC. (ATR) and BWX Technologies, Inc. (BWXT). Click either name above to swap in a different company.
APTARGROUP, INC. is the larger business by last-quarter revenue ($962.7M vs $885.8M, roughly 1.1× BWX Technologies, Inc.). BWX Technologies, Inc. runs the higher net margin — 10.5% vs 7.7%, a 2.8% gap on every dollar of revenue. On growth, BWX Technologies, Inc. posted the faster year-over-year revenue change (18.7% vs 13.5%). APTARGROUP, INC. produced more free cash flow last quarter ($96.9M vs $56.8M). Over the past eight quarters, BWX Technologies, Inc.'s revenue compounded faster (21.1% CAGR vs 2.6%).
AptarGroup, Inc., also known as Aptar, is a United States–based global manufacturer of consumer dispensing packaging and drug delivery devices. The group has manufacturing operations in 18 countries.
BWX Technologies, Inc. is a company headquartered in Lynchburg, Virginia that supplies nuclear components and fuel internationally.
ATR vs BWXT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $962.7M | $885.8M |
| Net Profit | $74.3M | $93.0M |
| Gross Margin | — | — |
| Operating Margin | 11.0% | 10.4% |
| Net Margin | 7.7% | 10.5% |
| Revenue YoY | 13.5% | 18.7% |
| Net Profit YoY | -26.4% | 30.9% |
| EPS (diluted) | $1.13 | $1.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $962.7M | $885.8M | ||
| Q3 25 | $961.1M | $866.3M | ||
| Q2 25 | $966.0M | $764.0M | ||
| Q1 25 | $887.3M | $682.3M | ||
| Q4 24 | $848.1M | $746.3M | ||
| Q3 24 | $909.3M | $672.0M | ||
| Q2 24 | $910.1M | $681.5M | ||
| Q1 24 | $915.4M | $604.0M |
| Q4 25 | $74.3M | $93.0M | ||
| Q3 25 | $127.9M | $82.1M | ||
| Q2 25 | $111.7M | $78.4M | ||
| Q1 25 | $78.8M | $75.5M | ||
| Q4 24 | $100.9M | $71.0M | ||
| Q3 24 | $100.0M | $69.5M | ||
| Q2 24 | $90.5M | $73.0M | ||
| Q1 24 | $83.1M | $68.5M |
| Q4 25 | — | — | ||
| Q3 25 | — | 21.8% | ||
| Q2 25 | — | 25.1% | ||
| Q1 25 | — | 24.2% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 24.4% | ||
| Q2 24 | — | 24.7% | ||
| Q1 24 | — | 24.6% |
| Q4 25 | 11.0% | 10.4% | ||
| Q3 25 | 14.2% | 13.1% | ||
| Q2 25 | 14.9% | 13.4% | ||
| Q1 25 | 12.8% | 14.2% | ||
| Q4 24 | 14.2% | 12.4% | ||
| Q3 24 | 15.2% | 14.4% | ||
| Q2 24 | 13.8% | 14.5% | ||
| Q1 24 | 12.2% | 15.4% |
| Q4 25 | 7.7% | 10.5% | ||
| Q3 25 | 13.3% | 9.5% | ||
| Q2 25 | 11.6% | 10.3% | ||
| Q1 25 | 8.9% | 11.1% | ||
| Q4 24 | 11.9% | 9.5% | ||
| Q3 24 | 11.0% | 10.3% | ||
| Q2 24 | 9.9% | 10.7% | ||
| Q1 24 | 9.1% | 11.3% |
| Q4 25 | $1.13 | $1.02 | ||
| Q3 25 | $1.92 | $0.89 | ||
| Q2 25 | $1.67 | $0.85 | ||
| Q1 25 | $1.17 | $0.82 | ||
| Q4 24 | $1.48 | $0.77 | ||
| Q3 24 | $1.48 | $0.76 | ||
| Q2 24 | $1.34 | $0.79 | ||
| Q1 24 | $1.23 | $0.75 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $409.5M | $499.8M |
| Total DebtLower is stronger | $1.1B | — |
| Stockholders' EquityBook value | $2.7B | $1.2B |
| Total Assets | $5.3B | $4.3B |
| Debt / EquityLower = less leverage | 0.43× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $409.5M | $499.8M | ||
| Q3 25 | $264.8M | $79.6M | ||
| Q2 25 | $169.8M | $37.0M | ||
| Q1 25 | $136.8M | $55.4M | ||
| Q4 24 | $226.2M | $74.1M | ||
| Q3 24 | $327.9M | $35.5M | ||
| Q2 24 | $223.9M | $48.3M | ||
| Q1 24 | $201.1M | $45.9M |
| Q4 25 | $1.1B | — | ||
| Q3 25 | $546.0M | — | ||
| Q2 25 | $535.1M | — | ||
| Q1 25 | $561.2M | — | ||
| Q4 24 | $688.1M | — | ||
| Q3 24 | $822.7M | — | ||
| Q2 24 | $681.5M | — | ||
| Q1 24 | $680.4M | — |
| Q4 25 | $2.7B | $1.2B | ||
| Q3 25 | $2.8B | $1.2B | ||
| Q2 25 | $2.7B | $1.2B | ||
| Q1 25 | $2.5B | $1.1B | ||
| Q4 24 | $2.5B | $1.1B | ||
| Q3 24 | $2.5B | $1.1B | ||
| Q2 24 | $2.4B | $998.5M | ||
| Q1 24 | $2.3B | $946.2M |
| Q4 25 | $5.3B | $4.3B | ||
| Q3 25 | $5.1B | $3.8B | ||
| Q2 25 | $4.9B | $3.7B | ||
| Q1 25 | $4.5B | $3.1B | ||
| Q4 24 | $4.4B | $2.9B | ||
| Q3 24 | $4.6B | $2.9B | ||
| Q2 24 | $4.5B | $2.8B | ||
| Q1 24 | $4.4B | $2.8B |
| Q4 25 | 0.43× | — | ||
| Q3 25 | 0.20× | — | ||
| Q2 25 | 0.20× | — | ||
| Q1 25 | 0.22× | — | ||
| Q4 24 | 0.28× | — | ||
| Q3 24 | 0.32× | — | ||
| Q2 24 | 0.28× | — | ||
| Q1 24 | 0.29× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $183.7M | $127.0M |
| Free Cash FlowOCF − Capex | $96.9M | $56.8M |
| FCF MarginFCF / Revenue | 10.1% | 6.4% |
| Capex IntensityCapex / Revenue | 9.0% | 7.9% |
| Cash ConversionOCF / Net Profit | 2.47× | 1.37× |
| TTM Free Cash FlowTrailing 4 quarters | $299.6M | $295.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $183.7M | $127.0M | ||
| Q3 25 | $177.6M | $143.2M | ||
| Q2 25 | $126.0M | $159.0M | ||
| Q1 25 | $82.7M | $50.6M | ||
| Q4 24 | $178.2M | $276.9M | ||
| Q3 24 | $229.3M | $32.6M | ||
| Q2 24 | $143.6M | $65.9M | ||
| Q1 24 | $92.3M | $33.0M |
| Q4 25 | $96.9M | $56.8M | ||
| Q3 25 | $114.3M | $94.9M | ||
| Q2 25 | $62.5M | $126.3M | ||
| Q1 25 | $25.9M | $17.3M | ||
| Q4 24 | $112.2M | $224.4M | ||
| Q3 24 | $162.7M | $-7.7M | ||
| Q2 24 | $75.4M | $35.5M | ||
| Q1 24 | $16.7M | $2.6M |
| Q4 25 | 10.1% | 6.4% | ||
| Q3 25 | 11.9% | 11.0% | ||
| Q2 25 | 6.5% | 16.5% | ||
| Q1 25 | 2.9% | 2.5% | ||
| Q4 24 | 13.2% | 30.1% | ||
| Q3 24 | 17.9% | -1.1% | ||
| Q2 24 | 8.3% | 5.2% | ||
| Q1 24 | 1.8% | 0.4% |
| Q4 25 | 9.0% | 7.9% | ||
| Q3 25 | 6.6% | 5.6% | ||
| Q2 25 | 6.6% | 4.3% | ||
| Q1 25 | 6.4% | 4.9% | ||
| Q4 24 | 7.8% | 7.0% | ||
| Q3 24 | 7.3% | 6.0% | ||
| Q2 24 | 7.5% | 4.5% | ||
| Q1 24 | 8.3% | 5.0% |
| Q4 25 | 2.47× | 1.37× | ||
| Q3 25 | 1.39× | 1.74× | ||
| Q2 25 | 1.13× | 2.03× | ||
| Q1 25 | 1.05× | 0.67× | ||
| Q4 24 | 1.77× | 3.90× | ||
| Q3 24 | 2.29× | 0.47× | ||
| Q2 24 | 1.59× | 0.90× | ||
| Q1 24 | 1.11× | 0.48× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ATR
| Pharma Segment | $833.1M | 87% |
| Other | $129.6M | 13% |
BWXT
| Nuclear Component Program | $436.4M | 49% |
| Nuclear Manufacturing | $134.8M | 15% |
| Cost Plus Fee | $116.1M | 13% |
| Uranium And Nuclear Services | $103.8M | 12% |
| Commercial Operations | $49.0M | 6% |
| Commercial Operations Segment | $33.7M | 4% |
| Transferred At Point In Time | $1.3M | 0% |
